|
ABCL AbCellera Biologics Inc 1703057 |
| Balance Sheet |
|
Current Assets
|
$679,230,000.00 |
|
Assets
|
$1,307,575,000.00 |
|
Current Liabilities
|
$53,189,000.00 |
|
Liabilities
|
$411,555,000.00 |
|
Equity
|
$896,020,000.00 |
|
Shares Out
|
306469632.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-7,600,000.00 |
|
Investing Cash Flow
|
$-13,740,000.00 |
| Market Analysis |
Market Cap
|
$3,545,853,642.24 |
|
Price
|
$11.57 |
|
BVPS
|
2.92 |
|
PB
|
3.96 |
|
EPS
|
-0.18 |
|
PS
|
218.88 |
|
FCF
|
$-13,563,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-24 |
-0.03 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-11 |
-0.14 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.12 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.19 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ABCL documents filed with the SEC.
ABCL Filings
Clear
